| - GRCh37:
- Chr3:178938895
- GRCh38:
- Chr3:179221107
| PIK3CA | I713V | Megalencephaly-capillary malformation-polymicrogyria syndrome | Uncertain significance (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:178938931
- GRCh38:
- Chr3:179221143
| PIK3CA | D725N | Megalencephaly-capillary malformation-polymicrogyria syndrome | Likely pathogenic (Nov 27, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:178928068
- GRCh38:
- Chr3:179210280
| PIK3CA | P449L | Megalencephaly-capillary malformation-polymicrogyria syndrome | Pathogenic (Feb 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:178947841
- GRCh38:
- Chr3:179230053
| PIK3CA | V906L | Megalencephaly-capillary malformation-polymicrogyria syndrome | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr3:178952072
- GRCh38:
- Chr3:179234284
| PIK3CA | M1043L | Megalencephaly-capillary malformation-polymicrogyria syndrome | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:178928067
- GRCh38:
- Chr3:179210279
| PIK3CA | P449T | Megalencephaly-capillary malformation-polymicrogyria syndrome | Pathogenic/Likely pathogenic (Jan 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178952049
- GRCh38:
- Chr3:179234261
| PIK3CA | A1035V | PIK3CA related overgrowth syndrome | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr3:178916957
- GRCh38:
- Chr3:179199169
| PIK3CA | R115P | PIK3CA-related disorder | Likely pathogenic (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:178948044
- GRCh38:
- Chr3:179230256
| PIK3CA | D939G | Segmental undergrowth associated with mainly venous malformation with capillary component, See cases, Megalencephaly-capillary malformation-polymicrogyria syndrome
| Pathogenic/Likely pathogenic (Dec 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178922363
- GRCh38:
- Chr3:179204575
| PIK3CA | C378R | Megalencephaly-capillary malformation-polymicrogyria syndrome, CLOVES syndrome | Pathogenic | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178928067
- GRCh38:
- Chr3:179210279
| PIK3CA | P449S | not provided, Megalencephaly-capillary malformation-polymicrogyria syndrome | Pathogenic/Likely pathogenic (Nov 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178916614
- GRCh38:
- Chr3:179198826
| PIK3CA | M1V | Epidermal nevus, Megalencephaly-capillary malformation-polymicrogyria syndrome, Cowden syndrome
| Uncertain significance (Oct 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178922321
- GRCh38:
- Chr3:179204533
| PIK3CA | G364R | Megalencephaly-capillary malformation-polymicrogyria syndrome, PIK3CA related overgrowth syndrome, not provided
| Pathogenic/Likely pathogenic (Oct 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178917561
- GRCh38:
- Chr3:179199773
| PIK3CA | V146I | Cowden syndrome, Seborrheic keratosis, CLAPO syndrome, CLOVES syndrome, Neoplasm of stomach, Congenital macrodactylia, Epidermal nevus, Neoplasm of ovary, Carcinoma of colon, Familial cancer of breast, Cowden syndrome 5Hepatocellular carcinoma, Megalencephaly-capillary malformation-polymicrogyria syndrome, Lung carcinoma, not provided, ...see more | Uncertain significance (Aug 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178947215
- GRCh38:
- Chr3:179229427
| PIK3CA | K884R | Congenital macrodactylia, Seborrheic keratosis, Familial cancer of breast, Stomach cancer, CLAPO syndrome, Cowden syndrome 5, Hepatocellular carcinoma, Colorectal cancer, CLOVES syndrome, Lung cancer, Megalencephaly-capillary malformation-polymicrogyria syndromeEpidermal nevus, Neoplasm of ovary, Inborn genetic diseases, not specified, Cowden syndrome, not provided, ...see more | Uncertain significance (May 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178922324
- GRCh38:
- Chr3:179204536
| PIK3CA | E365K | Megalencephaly-capillary malformation-polymicrogyria syndrome, PIK3CA-related condition, Cowden syndrome, Angioosteohypertrophic syndrome, not provided | Pathogenic (Feb 2, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178921566
- GRCh38:
- Chr3:179203778
| PIK3CA | D350N | PIK3CA related overgrowth syndrome, not provided | Pathogenic/Likely pathogenic (Nov 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178922361
- GRCh38:
- Chr3:179204573
| PIK3CA | P377R | PIK3CA-related condition, Cowden syndrome, Seborrheic keratosis, Megalencephaly-capillary malformation-polymicrogyria syndrome, CLAPO syndrome, CLOVES syndrome, Neoplasm of stomach, Cowden syndrome 5, Familial cancer of breast, Lung carcinoma, Congenital macrodactyliaHepatocellular carcinoma, Epidermal nevus, Neoplasm of ovary, Carcinoma of colon, ...see more | Uncertain significance (Nov 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178921552
- GRCh38:
- Chr3:179203764
| PIK3CA | N345T | Megalencephaly-capillary malformation-polymicrogyria syndrome, Noonan syndrome 8 | Pathogenic (Sep 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:178916854
- GRCh38:
- Chr3:179199066
| PIK3CA | E81K | Cowden syndrome, not provided, CLOVES syndrome
| Pathogenic (Jun 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178938934
- GRCh38:
- Chr3:179221146
| PIK3CA | E726K | Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes | Pathogenic (Feb 12, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr3:178928079
- GRCh38:
- Chr3:179210291
| PIK3CA | E453K | not provided, Megalencephaly-capillary malformation-polymicrogyria syndrome, PIK3CA related overgrowth syndrome, Cowden syndrome, PIK3CA-related disorder, CLOVES syndrome
| Pathogenic (Jun 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178952090
- GRCh38:
- Chr3:179234302
| PIK3CA | G1049S | not provided, Megalencephaly-capillary malformation-polymicrogyria syndrome | Pathogenic (Mar 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178936074
- GRCh38:
- Chr3:179218286
| PIK3CA | P539R | Megalencephaly-capillary malformation-polymicrogyria syndrome | Likely pathogenic (Oct 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:178921553
- GRCh38:
- Chr3:179203765
| PIK3CA | N345K | not provided, Familial cancer of breast, Congenital macrodactylia, Hepatocellular carcinoma, Colorectal cancer, Stomach cancer, Seborrheic keratosis, Megalencephaly-capillary malformation-polymicrogyria syndrome, Neoplasm of ovary, Lung cancer, CLAPO syndromeCLOVES syndrome, Epidermal nevus, Cowden syndrome 5, ...see more | Pathogenic (Mar 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178916876
- GRCh38:
- Chr3:179199088
| PIK3CA | R88Q | Cowden syndrome, PIK3CA related overgrowth syndrome, Megalencephaly-capillary malformation-polymicrogyria syndrome, not provided | Pathogenic (Jan 10, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178916936
- GRCh38:
- Chr3:179199148
| PIK3CA | R108H | See cases, not provided, Cowden syndrome, not specified, Megalencephaly-capillary malformation-polymicrogyria syndrome | Conflicting interpretations of pathogenicity (May 14, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:155874166
- GRCh38:
- Chr1:155904375
| RIT1 | R122L, R139L, R86L | not provided, Megalencephaly-capillary malformation-polymicrogyria syndrome, Noonan syndrome 8, Noonan syndrome and Noonan-related syndrome, Noonan syndrome 8 | Conflicting interpretations of pathogenicity (Aug 8, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:178916948
- GRCh38:
- Chr3:179199160
| PIK3CA | I112N | Megalencephaly-capillary malformation-polymicrogyria syndrome | Pathogenic (Oct 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:178936093
- GRCh38:
- Chr3:179218305
| PIK3CA | E545D | Megalencephaly-capillary malformation-polymicrogyria syndrome, Cowden syndrome | Pathogenic/Likely pathogenic (Jun 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178952074
- GRCh38:
- Chr3:179234286
| PIK3CA | M1043I | Megalencephaly-capillary malformation-polymicrogyria syndrome, Cowden syndrome, not provided, Non-small cell lung carcinoma | Pathogenic/Likely pathogenic (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:243776983
- GRCh38:
- Chr1:243613681
| AKT3 | N229S | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, Megalencephaly-capillary malformation-polymicrogyria syndrome | Pathogenic (Nov 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr19:18273784
- GRCh38:
- Chr19:18162974
| PIK3R2 | G373R | Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes | Pathogenic (Feb 17, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr3:178928078-178928080
- GRCh38:
- Chr3:179210290-179210292
| PIK3CA | E453del | not provided | Pathogenic (Apr 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178952084
- GRCh38:
- Chr3:179234296
| PIK3CA | H1047Y | PIK3CA related overgrowth syndrome, Congenital macrodactylia, Epidermal nevus, Neoplasm of ovary, CLOVES syndrome, Familial cancer of breast, Neoplasm of stomach, Megalencephaly-capillary malformation-polymicrogyria syndrome, Lung carcinoma, CLAPO syndrome, Hepatocellular carcinomaSeborrheic keratosis, Carcinoma of colon, Cowden syndrome 5, Cowden syndrome, not provided, Megalencephaly-capillary malformation-polymicrogyria syndrome, CLOVES syndrome, Non-small cell lung carcinoma, Segmental undergrowth associated with mainly venous malformation with capillary component, ...see more | Pathogenic (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178922364
- GRCh38:
- Chr3:179204576
| PIK3CA | C378Y | PIK3CA related overgrowth syndrome, Megalencephaly-capillary malformation-polymicrogyria syndrome, PIK3CA-related condition, Cowden syndrome | Pathogenic (Feb 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178947865
- GRCh38:
- Chr3:179230077
| PIK3CA | G914R | Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes | Pathogenic (Feb 12, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr3:178936091
- GRCh38:
- Chr3:179218303
| PIK3CA | E545K | Eccrine Angiomatous Hamartoma, PIK3CA related overgrowth syndrome, not provided, CLOVES syndrome, Segmental undergrowth associated with lymphatic malformation | Pathogenic/Likely pathogenic (Jan 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178952085
- GRCh38:
- Chr3:179234297
| PIK3CA | H1047L | Colorectal cancer, not provided, Megalencephaly-capillary malformation-polymicrogyria syndrome, Hemihypertrophy, Cowden syndrome 1, Stroke, Macrodactyly of toe | Pathogenic (Apr 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178952085
- GRCh38:
- Chr3:179234297
| PIK3CA | H1047R | Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes | Pathogenic (Feb 11, 2022) | reviewed by expert panel FDA Recognized Database |